King TA - Search Results

1

Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.

Dominici LS, Sineshaw HM, Jemal A, Lin CC, King TA, Freedman RA. Dominici LS, et al. Among authors: king ta. Breast Cancer Res Treat. 2018 Jan;167(2):555-566. doi: 10.1007/s10549-017-4528-6. Epub 2017 Oct 9. Breast Cancer Res Treat. 2018. PMID: 28990127

2

Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.

King TA, Ganaraj A, Fey JV, Tan LK, Hudis C, Norton L, Cody HS 3rd, Borgen PI. King TA, et al. Cancer. 2004 Sep 1;101(5):926-33. doi: 10.1002/cncr.20517. Cancer. 2004. PMID: 15329899 Free article.

3

Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?

McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA. McLaughlin SA, et al. Among authors: king ta. Cancer. 2008 Mar 15;112(6):1214-21. doi: 10.1002/cncr.23298. Cancer. 2008. PMID: 18257089 Free article.

4

Changing indications for surgery in patients with stage IV breast cancer: a current perspective.

Morrogh M, Park A, Norton L, King TA. Morrogh M, et al. Among authors: king ta. Cancer. 2008 Apr 1;112(7):1445-54. doi: 10.1002/cncr.23319. Cancer. 2008. PMID: 18306353 Free article.

5

Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?

Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Neuman HB, et al. Among authors: king ta. Cancer. 2010 Mar 1;116(5):1226-33. doi: 10.1002/cncr.24873. Cancer. 2010. PMID: 20101736 Free PMC article.

6

A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer.

Morrogh M, Miner TJ, Park A, Jenckes A, Gonen M, Seidman A, Morrow M, Jaques DP, King TA. Morrogh M, et al. Among authors: king ta. Cancer. 2010 Jul 15;116(14):3338-47. doi: 10.1002/cncr.25034. Cancer. 2010. PMID: 20564060 Free PMC article.

7

Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.

Ho AY, Gupta G, King TA, Perez CA, Patil SM, Rogers KH, Wen YH, Brogi E, Morrow M, Hudis CA, Traina T, McCormick B, Powell SN, Robson ME. Ho AY, et al. Among authors: king ta. Cancer. 2012 Oct 15;118(20):4944-52. doi: 10.1002/cncr.27480. Epub 2012 Mar 5. Cancer. 2012. PMID: 22392492 Free article.

8

Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.

Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Dengel LT, et al. Among authors: king ta. Ann Surg Oncol. 2014 Jan;21(1):22-7. doi: 10.1245/s10434-013-3200-6. Epub 2013 Aug 22. Ann Surg Oncol. 2014. PMID: 23975314 Free PMC article.

9

Is there a role for routine screening MRI in women with LCIS?

King TA, Muhsen S, Patil S, Koslow S, Oskar S, Park A, Morrogh M, Sakr RA, Morrow M. King TA, et al. Breast Cancer Res Treat. 2013 Nov;142(2):445-53. doi: 10.1007/s10549-013-2725-5. Epub 2013 Oct 19. Breast Cancer Res Treat. 2013. PMID: 24141896 Free PMC article.

10

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

Fackler MJ, Lopez Bujanda Z, Umbricht C, Teo WW, Cho S, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Lyman JP, de Brot M, Ingle JN, Boughey J, McGuire K, King TA, Carey LA, Cope L, Wolff AC, Sukumar S. Fackler MJ, et al. Among authors: king ta. Cancer Res. 2014 Apr 15;74(8):2160-70. doi: 10.1158/0008-5472.CAN-13-3392. Cancer Res. 2014. PMID: 24737128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page